A novel cancer immunotherapy combines rMVA-CD40L with tumor targeting antibodies

Poster presented at the CIMT 2019 Annual Meeting in Mainz, Germany, May 21-23, 2019

Download poster
Synergistic cancer immunotherapy combination of MVA-CD40L with tumor targeting antibodies or checkpoint blockade to achieve strong antitumor immune responses against large, established tumors

Poster presented at AACR Annual Meeting 2019 in Atlanta, Georgia, USA March 29 - April 3, 2019.

Download poster
Novel applications of MVA to improve outcomes in immunooncology

Poster presented at International Congress on Targeted Anticancer Therapies (TAT) in Paris, 25-27 February 2019.

Download poster